Immediate Impact
16 from Science/Nature 57 standout
Citing Papers
Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Julia Rohrberg being referenced
A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression.
2020
Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Julia Rohrberg | 666 | 111 | 32 | 129 | 126 | 10 | 762 | |
| Olesya V. Bukach | 630 | 147 | 21 | 112 | 148 | 14 | 714 | |
| J.J. Warren | 782 | 46 | 8 | 113 | 141 | 10 | 912 | |
| Lilia Stepanova | 602 | 187 | 22 | 67 | 98 | 8 | 693 | |
| Suman Chatterjee | 556 | 163 | 114 | 37 | 118 | 9 | 711 | |
| Marton I. Siklos | 494 | 168 | 30 | 57 | 75 | 16 | 750 | |
| Michael Wong | 711 | 210 | 53 | 42 | 253 | 15 | 909 | |
| Matthias Zeiner | 604 | 49 | 22 | 102 | 79 | 10 | 676 | |
| Erica O’Bryan | 705 | 131 | 19 | 27 | 80 | 8 | 922 | |
| Ganesan Srinivasan | 520 | 82 | 37 | 44 | 56 | 18 | 752 | |
| MV Blagosklonny | 546 | 185 | 30 | 22 | 103 | 9 | 771 |
All Works
Login with ORCID to disown or claim papers
Loading papers...